<DOC>
	<DOC>NCT00812188</DOC>
	<brief_summary>Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.</brief_summary>
	<brief_title>Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.</brief_title>
	<detailed_description />
	<mesh_term>Scleroderma, Localized</mesh_term>
	<mesh_term>Fluocinonide</mesh_term>
	<criteria>Male and female subjects 18 years of age or older. Symmetric limited morphea. Known sensitivity to fluocinonide 0.05% cream. Clinical evidence of superinfected skin. Immunocompromised state (including previously documented HIV). Generalized Scleroderma. Previous history of skin cancer. NonEnglish speaking subjects.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Morphea</keyword>
	<keyword>Plaque morphea</keyword>
	<keyword>Localized Scleroderma</keyword>
</DOC>